A detailed history of Sawtooth Solutions, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Sawtooth Solutions, LLC holds 24,669 shares of ALKS stock, worth $709,480. This represents 0.02% of its overall portfolio holdings.

Number of Shares
24,669
Previous 13,060 88.89%
Holding current value
$709,480
Previous $365,000 87.4%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

BUY
$23.37 - $28.68 $271,302 - $332,946
11,609 Added 88.89%
24,669 $684,000
Q3 2023

Oct 19, 2023

SELL
$27.17 - $31.97 $82,895 - $97,540
-3,051 Reduced 18.94%
13,060 $365,000
Q2 2023

Jul 26, 2023

BUY
$28.34 - $33.63 $81,930 - $97,224
2,891 Added 21.87%
16,111 $504,000
Q1 2023

Apr 27, 2023

BUY
$25.31 - $29.02 $334,598 - $383,644
13,220 New
13,220 $372,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.72B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.